A publication involving macimorelin appeared on September 21, 2026. The paper, titled "Diagnostic accuracy of growth hormone stimulation tests for growth hormone deficiency following radiotherapy involving the hypothalamic-pituitary axis: protocol for a systematic review and planned meta-analysis," was published in BMJ Open.
This publication describes a protocol for a planned systematic review and meta-analysis. It focuses on diagnostic accuracy of growth hormone stimulation tests. The population of interest is patients with suspected growth hormone deficiency following radiotherapy involving the hypothalamic-pituitary axis.
As a protocol paper, this publication outlines the planned methodology for the future review. No results or findings from the systematic review or meta-analysis are reported in this publication. The paper establishes the framework under which growth hormone stimulation testing approaches, including macimorelin, will later be evaluated for diagnostic accuracy in this specific patient population.
Readers interested in learning more about macimorelin, including its approved regulatory status and general background, can consult the compound overview for additional context.